Gossamer Bio Inc. (GOSS) Tops Q2 EPS by 4c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.45), $0.04 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• After-Hours Stock Movers: FDX, CBRS, NKE